ETC
CGEM icon

Exchange Traded Concepts’s Cullinan Oncology CGEM Stock Holding History

Exchange Traded Concepts’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,107
Closed -$107K – 1422
2025
Q1 		$107K Buy
14,107
+4,216
+43% +$40.5K ﹤0.01% 1138
2024
Q4 		$120K Hold
9,891
– – ﹤0.01% 1114
2024
Q3 		$166K Sell
9,891
-2,961
-23% -$52.5K ﹤0.01% 1021
2024
Q2 		$224K Sell
12,852
-3,998
-24% -$85.1K 0.01% 860
2024
Q1 		$287K Buy
16,850
+2,774
+20% +$42.9K 0.01% 818
2023
Q4 		$143K Buy
14,076
+3,569
+34% +$31.6K ﹤0.01% 839
2023
Q3 		$95.1K Sell
10,507
-1,154
-10% -$12K ﹤0.01% 914
2023
Q2 		$125K Buy
+11,661
New +$124K ﹤0.01% 894

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Exchange Traded Concepts's CGEM Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Cullinan Oncology (CGEM) in Q2 2025, closing a stake of 14,107 shares — an estimated $107K sold.

Exchange Traded Concepts first reported a position in CGEM in Q2 2023 and held it in 8 quarters. The position peaked at $287K in Q1 2024. 143 funds tracked by Wall St. Rank hold CGEM as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Cullinan Oncology position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 14,107 Cullinan Oncology shares in Q2 2025, an estimated $107K.
  • Exchange Traded Concepts first reported a position in Cullinan Oncology in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Cullinan Oncology position peaked at $287K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.